CYP2C9*3/*3 Gene Expression Affects the Total and Free Concentrations of Valproic Acid in Pediatric Patients with Epilepsy
Xikun Wu,1 Weichong Dong,1 Haoran Li,1 Xiuling Yang,1 Yiran Jin,1 Zhiqing Zhang,1 Ye Jiang2 1The Second Hospital of Hebei Medical University, Shijiazhuang City, People’s Republic of China; 2Pharmacy College, Hebei Medical University, Shijiazhuang City, People’s Republic of ChinaC...
Main Authors: | Wu X, Dong W, Li H, Yang X, Jin Y, Zhang Z, Jiang Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-04-01
|
Series: | Pharmacogenomics and Personalized Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/cyp2c933-gene-expression-affects-the-total-and-free-concentrations-of--peer-reviewed-article-PGPM |
Similar Items
-
Therapeutic Drug Monitoring of Valproic Acid in Patients with
by: Mohsen Forooghipour, et al.
Published: (2009-09-01) -
Process of Personalized Prescription of Valproic Acid as the Main Element of the Management of Epilepsy
by: Elena N. Bochanova, et al.
Published: (2018-03-01) -
Therapeutic monitoring of valproic acid - benefits and problems
by: Agnieszka Małgorzata Cios, et al.
Published: (2021-05-01) -
Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury
by: Yirui Sun, et al.
Published: (2017-08-01) -
Effect of valproic acid on metabolic status and endocrine system in pediatric patients with epilepsy: systematic literature review
by: Sona Sepahi, et al.
Published: (2017-01-01)